i'm thinking they could raise capitol in the 5 handle range
we might see a little roatation out of higher risk equities as the market prepares for a pullback.
well thought our and writen
Openxky: good post... thanks man.
headed back down to 5.25
There are some very knowledgable people on this board. Hopefully, one of them will provide a detailed and accurate answer. I believe further trials will need to be done outside of the current one's to market to the sub 16 demogrphic. FDA labeling has not been discussed nor is until you get approval. Yet, Plecanatide has few side effects thus potentially the greater probability to target younget demo. the above is my humble and layman understanding.
If you looking to find a trading strategy check out trackingtheinsiders dotcom
tracking the insiders dotcom
Azteca Acquisition Corp
Luxor Capital Group, LP
10% Owner
882,700
Purchase at $10.18
$8,984,386
TTI
Tetra Technologies Inc
Longorio Philip N
SVP
56,100
Purchase at $8.92
$500,412
BBT
Bb&t Corp
Yates William Rufus
Sr. EVP
7,345
Purchase at $24.66
$181,098
Endeavour International Corp
O-Cap Management, L.P.
See Explanation of Responses, 10% Owner
95,200
Purchase at $3.37
$320,763
check out tracking the insiders dotcom for more info.
we new about the breakout yesterday
trackingtheinsiders dotcom
MMar 5 2013
SBUX
Starbucks Corp
Schultz Howard D
chairman, president, ceo
1,000,000
Sale at $57.13
$57,126,770
tracking the insiders dotcom... join now
GOOG
Google Inc.
Brin Sergey
Co-Founder, 10% Owner
83,334
Sale at $835.71
$69,642,768
tracking the insiders dotcom
JCP
J C Penney Co Inc
Roth Steven
Director
10,000,000
Sale at $16.03
$160,300,000
follow the insiders at tracking the insiders dotcom
Mar 7 09:36pm
MMar 6 2013
NR
MMar 5 2013
IACI
Iac/interactivecorp
Blatt Gregory R
CEO
248,507
Sale at $42.23
$10,494,704
MMar 5 2013
MNST
Monster Beverage Corp
Sacks Rodney C
Chairman, CEO
459,752
Sale at $48.73
$22,405,015